Title : Long Term Results of Lung Volume Reduction Surgery
COPD remains a leading cause of morbidity and mortality worldwide. For emphysema in particular, there are few effective treatments. The rediscovery and refinement of lung volume reduction surgery in the 1990’s let to the NETT trial in the early 2000’s. Despite encouraging results, LVRS remains underutilized.
At Columbia, we have an extensive lung failure and LVRS program that pre-dates the NETT trial. We plan to present our series of 139 consecutive LVRS cases over approximately the last 14 years. Our series demonstrates very low morbidity and almost no mortality. We also will demonstrate a sustained benefit in terms of symptoms and PFT’s. These data are particularly relevant given the recent advent of bronchoscopic valves for LVR. In addition, LVRS remains woefully underutilized to help palliate the debilitating symptoms of emphysema.
In summary, we will present arguably the largest series of LVRS operations with some of the longest follow up ever reported with excellent results to establish a baseline of excellence for this operation and a point of comparison for other interventions that aim to improve the lives of patients with emphysema.